Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Krystal Biotech (KRYS) Gross Profit (2023 - 2025)

Historic Gross Profit for Krystal Biotech (KRYS) over the last 3 years, with Q4 2025 value amounting to $100.5 million.

  • Krystal Biotech's Gross Profit rose 1665.04% to $100.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $366.1 million, marking a year-over-year increase of 3534.41%. This contributed to the annual value of $366.1 million for FY2025, which is 3535.8% up from last year.
  • According to the latest figures from Q4 2025, Krystal Biotech's Gross Profit is $100.5 million, which was up 1665.04% from $93.5 million recorded in Q3 2025.
  • In the past 5 years, Krystal Biotech's Gross Profit ranged from a high of $100.5 million in Q4 2025 and a low of $8.3 million during Q3 2023
  • For the 3-year period, Krystal Biotech's Gross Profit averaged around $68.4 million, with its median value being $80.2 million (2024).
  • Per our database at Business Quant, Krystal Biotech's Gross Profit skyrocketed by 82592.1% in 2024 and then skyrocketed by 1665.04% in 2025.
  • Quarter analysis of 3 years shows Krystal Biotech's Gross Profit stood at $39.3 million in 2023, then soared by 119.4% to $86.2 million in 2024, then increased by 16.65% to $100.5 million in 2025.
  • Its last three reported values are $100.5 million in Q4 2025, $93.5 million for Q3 2025, and $88.9 million during Q2 2025.